Immutep not only leads the way with its LAG-3 research but sets the research standard because it was discovered by its Chief Scientific Officer and Chief Medical Officer Dr. Frederic Triebel. This alone has put Immutep as a global leader of immunotherapy drugs for cancer and autoimmune diseases.
“It’s really what we do. We are a LAG-3 company. We have more programs built around LAG-3 than even anyone, including in the Pharma space,” said Immutep CEO Marc Voigt. “The reality is, there has not been a new, approved or validated checkpoint in the past six years. LAG-3 is our opportunity to be the next big thing in immunization technology.”
Some pretty confident statements made there
- Forums
- ASX - By Stock
- IMM
- Interesting read
Interesting read, page-2
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
39.3¢ |
Change
-0.003(0.63%) |
Mkt cap ! $573.7M |
Open | High | Low | Value | Volume |
39.0¢ | 39.8¢ | 39.0¢ | $1.535M | 3.911M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 54172 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 139580 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 54479 | 0.390 |
16 | 124461 | 0.385 |
13 | 87279 | 0.380 |
8 | 58610 | 0.375 |
10 | 121124 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 138327 | 29 |
0.400 | 153882 | 16 |
0.405 | 251190 | 9 |
0.410 | 248273 | 11 |
0.415 | 200197 | 11 |
Last trade - 13.21pm 06/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |